Ionizing Radiation and Leukemia Mortality among Japanese Atomic Bomb Survivors, 1950–2000

@inproceedings{Richardson2009IonizingRA,
  title={Ionizing Radiation and Leukemia Mortality among Japanese Atomic Bomb Survivors, 1950–2000},
  author={D. Richardson and H. Sugiyama and N. Nishi and R. Sakata and Y. Shimizu and E. Grant and M. Soda and W. Hsu and A. Suyama and K. Kodama and F. Kasagi},
  booktitle={Radiation research},
  year={2009}
}
Abstract This paper provides the first comprehensive report on mortality by type of leukemia among the Japanese atomic bomb survivors in the Life Span Study (LSS). Analyses include 310 deaths due to leukemia during the period 1950–2000 among 86,611 people in the LSS. Poisson regression methods were used to evaluate associations between estimated bone marrow dose and leukemia mortality. Attention was given to variation in the radiation dose–leukemia mortality association by time since exposure… Expand
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001
TLDR
Analysis of radiation effects on leukemia, lymphoma and multiple myeloma incidence in the Life Span Study cohort of atomic bomb survivors updated 14 years since the last comprehensive report on these malignancies found that ERR models can often provide equivalent and sometimes more parsimonious descriptions of the excess risk than EAR models. Expand
Leukemia Risk Associated with Chronic External Exposure to Ionizing Radiation in a French Cohort of Nuclear Workers
Leukemia is one of the earliest cancer effects observed after acute exposure to relatively high doses of ionizing radiation. Leukemia mortality after external exposure at low doses and low-dose ratesExpand
Occupational Radiation Exposure and Leukemia Mortality among Nuclear Workers in Japan: J-EPISODE, 1991-2010
TLDR
A significant radiation-leukemia association for mortality was not observed in this study of Japanese nuclear workers, and further followup is needed to obtain more reliable estimates of leukemia risks for Japanese workers exposed to low dose and low-dose rate radiation. Expand
Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases
TLDR
The risk of cancer mortality increased significantly for most major sites, including stomach, lung, liver, colon, breast, gallbladder, esophagus, bladder and ovary, whereas rectum, pancreas, uterus, prostate and kidney parenchyma did not have significantly increased risks. Expand
Late effect of Atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes
TLDR
It is suggested that the risk of radiation-induced hematological malignancies has persisted for six decades since the initial exposure to atomic bomb radiation. Expand
Risk of childhood leukemia after low-level exposure to ionizing radiation
TLDR
It is shown that for those exposed as children, the proportional increase in the risk of leukemia is expressed over time as a distinct ‘wave’. Expand
Radiation effects on cancer risks in the Life Span Study cohort.
TLDR
In view of the nature of the continuing increase in solid cancers, the LSS should continue to provide important new information on cancer risks, as most survivors still alive today were exposed to the atomic bomb radiation under the age of 20 y and are now entering their cancer-prone years. Expand
Epidemiological research on radiation-induced cancer in atomic bomb survivors
  • K. Ozasa
  • Medicine
  • Journal of radiation research
  • 2016
The late effects of exposure to atomic bomb radiation on cancer occurrence have been evaluated by epidemiological studies on three cohorts: a cohort of atomic bomb survivors (Life Span Study; LSS),Expand
Examining temporal effects on cancer risk in the international nuclear workers’ study
TLDR
Persistent or late effects suggest additional follow‐up may inform on lifetime risks, and cautious interpretation of results is needed due to analytical limitations and a lack of confirmatory results from other studies. Expand
Radiation and cancer risk in atomic-bomb survivors.
  • K. Kodama, K. Ozasa, T. Okubo
  • Medicine
  • Journal of radiological protection : official journal of the Society for Radiological Protection
  • 2012
TLDR
Given the continuing solid cancer increase in the survivor population, the LSS will likely continue to provide important new information on radiation exposure and solid cancer risks for another 15-20 years, especially for those exposed at a young age. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
This paper presents an analysis of data on the incidence of leukemia, lymphoma and myeloma in the Life Span Study cohort of atomic bomb survivors during the period from late 1950 through the end ofExpand
Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
This article summarizes the risk of cancer among the survivors of the atomic bombing of Hiroshima and Nagasaki. We focus primarily on the risk of death from cancer among individuals in the Life SpanExpand
Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
This article summarizes the risk of cancer among the survivors of the atomic bombing of Hiroshima and Nagasaki. We focus primarily on the risk of death from cancer among individuals in the Life SpanExpand
Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982.
This study extends an earlier one by 4 years (1979-1982) and includes mortality data on 11,393 additional Nagasaki survivors. Significant dose responses are observed for leukemia, multiple myeloma,Expand
Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan.
Abstract Data have been presented concerning the incidence and death rate from leukemia for the years 1948, 1949 and 1950 in the populations of Hiroshima and Nagasaki, Japan, which were exposed toExpand
Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
More than 30 years ago, population-based tumor registries were established in Hiroshima and Nagasaki. This report, the first of a series of papers on cancer incidence, describes methodologicalExpand
Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
The incidence of malignant tumors in the Radiation Effects Research Foundation (RERF) Life Span Study (LSS) sample in Nagasaki as revealed by the Nagasaki Tumor Registry was investigated for theExpand
A-bomb data: detection of bias in the Life Span Study cohort.
  • A. Stewart
  • Medicine
  • Environmental health perspectives
  • 1997
By drawing a distinction between A-bomb survivors with and without bomb-related injuries, it was possible to see that instead of the Life Span Study (LSS) cohort being a normal, homogenousExpand
Effect of Recent Changes in Atomic Bomb Survivor Dosimetry on Cancer Mortality Risk Estimates
Abstract Preston, D. L., Pierce, D. A., Shimizu, Y., Cullings, H. M., Fujita, S., Funamoto, S. and Kodama, K. Effect of Recent Changes in Atomic Bomb Survivor Dosimetry on Cancer Mortality RiskExpand
Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan.
The objective of the present study was to investigate the association between human T‐lymphotropic virus type‐1 (HTLV‐1) infection and cancer risk in a longitudinal study. The study populationExpand
...
1
2
3
...